Skip to main content
Image of a human injecting themselves with semaglutide

Medicine’s Rong Xu links semaglutide to lower Alzheimer’s risk in Type 2 diabetes patients

Media | November 02, 2026 | Story by: Editorial Staff

Drugs like Ozempic and Wegovy are linked to a lower risk of Alzheimer’s disease, new study says

Fortune Magazine: Rong Xu,  professor at the School of Medicine, said semaglutide, the active ingredient in Ozempic and Wegovy, was associated with a 40% to 70% lower risk of Alzheimer’s diagnosis among nearly 1 million people with Type 2 diabetes, according to Case Western Reserve research. She cautioned that the findings show an association, not proof of prevention. 

EXPLORE MORE:
School of Medicine, Media